Holding the line on HIV prices

GSK is not concerned that managed care plans will ask for HIV drug price discounts similar to those given to South Africa, Garnier declared. "I was very encouraged to see some of the tougher HMOs in America, tougher in the sense of their negotiating stand with the pharmaceutical industry, make a public statement - which certainly we had nothing to do with - saying that they recognize what GSK was doing in Africa and would not take advantage to extract different discount rates from our HIV portfolio of drugs"